Blog

More news - Latest news Recent research has highlighted a potentially game-changing secondary benefit of Wegovy, an established obesity management drug. In a large clinical trial, individuals taking Wegovy were observed to have a significantly reduced death rate from Covid-19 compared to those not taking the drug. Clinical Trial Insights The study participants, who were already using Wegovy for obesity, contracted Covid-19 at the usual rate expected in the general population. However, their risk of succumbing to the virus was reduced by a third. This remarkable reduction in mortality was surprising and suggests an indirect benefit of the drug that…

Related media - Breaking news Health officials in the Northeast United States are stepping up warnings about Eastern Equine Encephalitis (EEE), a rare but potentially fatal mosquito-borne virus. Recent outbreaks have prompted increased vigilance and preventative measures in several states. Increased risk and community responses The resurgence of EEE has led to increased precautions, particularly in Massachusetts, where residents in several communities are advised to limit outdoor activities from dusk until dawn to avoid exposure to mosquitoes. This advice is underscored by the recent overnight closures of several parks and the tragic death of a person in New Hampshire from…

More news - Latest news In the mid-1990s, a deadly neurotoxin known to cause botulism was making headlines for its unexpected potential: erasing wrinkles. Newspapers dubbed it "Pretty Poison." Botulinum toxin was far more toxic than cyanide and had been explored as a potential chemical weapon. However, in the decades after World War II, Dr. Alan Scott, an eye doctor, saw promise in treating involuntary muscle spasms and crossed eyes. One surprising side effect: Patients’ eyebrows became as smooth as a baby’s. While Dr. Scott is known as the "father of Botox," the true pioneers of cosmetic Botox were Dr.…